cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick …
Over the last 12 months, insiders at cbdMD, Inc. have bought $0 and sold $0 worth of cbdMD, Inc. stock.
On average, over the past 5 years, insiders at cbdMD, Inc. have bought $311,539 and sold $1.45M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,000 shares for transaction amount of $10,500 was made by Kennedy Thomas Ronan (Interim CEO and CFO) on 2023‑05‑03.
2023-05-03 | Interim CEO and CFO | 5,000 18.1948% | $2.10 | $10,500 | -50.26% | |||
2021-08-24 | CFO & COO | 7,400 0.0135% | $2.04 | $15,096 | -52.09% | |||
2021-03-11 | Sale | Chairman & CO-CEO | 65,493 0.0024% | $3.93 | $257,564 | -52.73% | ||
2021-03-10 | Sale | Chairman & CO-CEO | 59,507 0.0025% | $4.04 | $240,117 | -48.00% | ||
2021-03-02 | Sale | director | 20,000 0.0008% | $4.04 | $80,748 | -46.46% | ||
2021-02-22 | Sale | CO-CEO, President, Director | 122,000 0.005% | $4.25 | $518,805 | -49.54% | ||
2021-02-19 | Sale | CO-CEO, President, Director | 3,000 0.0001% | $4.28 | $12,846 | -50.11% | ||
2021-02-19 | Sale | Chairman & CO-CEO | 240,035 0.0099% | $4.42 | $1.06M | -50.11% | ||
2021-02-18 | Sale | Chairman & CO-CEO | 113,104 0.0048% | $4.43 | $500,768 | -48.26% | ||
2021-02-17 | Sale | Chairman & CO-CEO | 42,461 0.0018% | $4.54 | $192,764 | -48.39% | ||
2020-08-14 | Sale | director | 10,000 0.0244% | $3.43 | $34,300 | -8.15% | ||
2020-03-09 | director | 25,000 0.0014% | $0.75 | $18,720 | +200.75% | |||
2020-01-27 | CFO & COO | 5,000 0.0003% | $1.06 | $5,300 | +90.09% | |||
2020-01-14 | CO-CEO | 250,000 0.0145% | $1.00 | $250,000 | +88.57% | |||
2020-01-14 | CO-CEO | 250,000 0.0145% | $1.00 | $250,000 | +88.57% | |||
2020-01-14 | director | 250,000 0.0145% | $1.00 | $250,000 | +88.57% | |||
2020-01-14 | director | 40,000 0.0023% | $1.00 | $40,000 | +88.57% | |||
2020-01-14 | CFO & COO | 15,000 0.0009% | $1.00 | $15,000 | +88.57% | |||
2020-01-14 | director | 40,000 0.0023% | $1.00 | $40,000 | +88.57% | |||
2020-01-14 | director | 30,000 0.0017% | $1.00 | $30,000 | +88.57% |
Sumichrast Martin A. | Chairman & CO-CEO | 1425344 25.7323% | $0.35 | 1 | 7 | +88.57% |
Ghiloni Peter J. | director | 300000 5.416% | $0.35 | 2 | 0 | +144.66% |
Elliott Mark S | CFO & COO | 51680 0.933% | $0.35 | 2 | 0 | +89.33% |
Stephen Scott G. | director | 41052 0.7411% | $0.35 | 1 | 0 | +88.57% |
Morris Gregory C | director | 17531 0.3165% | $0.35 | 1 | 0 | +88.57% |
Renaissance Technologies | $33,000.00 | 0.93 | 36,011 | +15.01% | +$4,307.02 | <0.0001 | |
Virtu Financial Llc | $19,000.00 | 0.52 | 19,940 | -14.65% | -$3,262.59 | <0.01 | |
UBS | $13,518.00 | 0.38 | 14,536 | New | +$13,518.00 | <0.0001 | |
The Vanguard Group | $12,129.00 | 0.34 | 13,042 | 0% | +$0 | <0.0001 | |
BlackRock | $10,842.00 | 0.3 | 11,658 | <0.01% | -$0.93 | <0.0001 |